EUROPACCESS

EUROPACCESS is a strategic joint venture and alliance of seven leading European pharmaceutical service providers, including CHAPPER healthcare, EURAXI, Intsel Chimos, ILAPO, TETRAGO, LENIS, and PHARMA INTERNATIONAL. Established in 2023, the partnership offers integrated commercialization, market access, and distribution solutions to help pharmaceutical manufacturers navigate complex healthcare systems across Europe and the UK. Its comprehensive suite of services spans the entire drug lifecycle, including early and expanded access programs, dossier submission, regulatory filings, quality assurance, pharmacovigilance, and temperature-controlled logistics. By combining deep local expertise with a broad geographic footprint, EUROPACCESS provides a seamless, one-stop market entry into more than 30 European healthcare systems, reaching over 6,000 hospitals.